Integral Diagnostics (Australia) Today
| IDX Stock | 2.89 0.03 1.03% |
Performance7 of 100
| Odds Of DistressOver 52
|
Integral Diagnostics is selling for under 2.89 as of the 27th of November 2024; that is 1.03 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 2.87. Integral Diagnostics has 52 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Integral Diagnostics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Moving together with Integral Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Integral Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Integral Diagnostics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Integral Diagnostics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| MD CEO | MBBCh MBA |
| Business Concentration | Health Care, Health Care Providers & Services, Health Care Equipment & Services, Health Care (View all Sectors) |
Integral Diagnostics (IDX) is traded on Australian Securities Exchange in Australia and employs 1,977 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 676.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Integral Diagnostics's market, we take the total number of its shares issued and multiply it by Integral Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Integral Diagnostics operates under Health Care Providers & Services sector and is part of Health Care industry. The entity has 233.96 M outstanding shares.
Integral Diagnostics generates positive cash flow from operations, but has no cash available
Check Integral Diagnostics Probability Of Bankruptcy
Ownership AllocationIntegral Diagnostics has a total of 233.96 Million outstanding shares. Integral Diagnostics retains significant amount of outstanding shares owned by insiders and institutional investors .Since such a large part of the company is not owned by regular investors, we recommend to check if there were significant buying or selling the Integral Diagnostics stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Integral Ownership Details
Integral Diagnostics Risk Profiles
Although Integral Diagnostics' alpha and beta are two of the key measurements used to evaluate Integral Diagnostics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.21 | |||
| Semi Deviation | 1.32 | |||
| Standard Deviation | 1.7 | |||
| Variance | 2.88 |
Integral Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Integral Diagnostics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Money Flow Index Now
Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators |
| All Next | Launch Module |
Integral Diagnostics Corporate Management
Elected by the shareholders, the Integral Diagnostics' board of directors comprises two types of representatives: Integral Diagnostics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Integral. The board's role is to monitor Integral Diagnostics' management team and ensure that shareholders' interests are well served. Integral Diagnostics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Integral Diagnostics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| LLB BA | Interim Secretary | Profile | |
| Mica Duncalfe | Chief Officer | Profile | |
| Scott Paterson | Chief Officer | Profile | |
| Julian Gully | Chief Officer | Profile | |
| Craig White | Chief Officer | Profile |
Additional Tools for Integral Stock Analysis
When running Integral Diagnostics' price analysis, check to measure Integral Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integral Diagnostics is operating at the current time. Most of Integral Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integral Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integral Diagnostics' price. Additionally, you may evaluate how the addition of Integral Diagnostics to your portfolios can decrease your overall portfolio volatility.